KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Work In Process (2016 - 2022)

Bio-Rad Laboratories has reported Work In Process over the past 14 years, most recently at $158.8 million for Q2 2022.

  • Quarterly Work In Process rose 6.88% to $158.8 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $158.8 million through Jun 2022, up 6.88% year-over-year, with the annual reading at $142.7 million for FY2021, 6.05% down from the prior year.
  • Work In Process was $158.8 million for Q2 2022 at Bio-Rad Laboratories, up from $153.2 million in the prior quarter.
  • Over five years, Work In Process peaked at $158.8 million in Q2 2022 and troughed at $140.9 million in Q2 2018.
  • The 5-year median for Work In Process is $148.9 million (2018), against an average of $148.4 million.
  • Year-over-year, Work In Process grew 12.89% in 2018 and then fell 8.17% in 2021.
  • A 5-year view of Work In Process shows it stood at $145.1 million in 2018, then rose by 0.74% to $146.1 million in 2019, then increased by 3.97% to $151.9 million in 2020, then decreased by 6.05% to $142.7 million in 2021, then grew by 11.25% to $158.8 million in 2022.
  • Per Business Quant, the three most recent readings for BIO's Work In Process are $158.8 million (Q2 2022), $153.2 million (Q1 2022), and $142.7 million (Q4 2021).